Leadership & Pay ·
Jazz Pharmaceuticals CFO Samantha Pearce to retire upon successor selection or June 30, 2027
JAZZJazz Pharmaceuticals plc
Samantha Pearce, Executive Vice President and Chief Commercial Officer of Jazz Pharmaceuticals plc, notified the company on October 6, 2026, of her intent to retire. Her departure will occur upon the earlier of the selection and appointment of a successor or June 30, 2027. The company plans to commence a formal search process for her replacement, considering both internal and external candidates. Jazz Pharmaceuticals plc is a biopharmaceutical company focused on developing and commercializing medicines for patients with serious diseases.